Hyperprolactinemic mice overexpressing PRL in the liver have enhanced levels of circulating vasoinhibin (46), and pharmacologically induced hyperprolactinemia results in higher levels of vasoinhibin in ocular tissues and fluids of rats (47) and humans (48). The gene discussed is PRL; the disease is hyperprolactinemia.